Susquehanna International Group
RCKT icon

Susquehanna International Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Susquehanna International Group’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.38M Buy
385,639
+192,209
+99% +$764K ﹤0.01% 7094
2025
Q4 		$679K Buy
193,430
+106,092
+121% +$363K ﹤0.01% 8100
2025
Q3 		$285K Sell
87,338
-64,900
-43% -$204K ﹤0.01% 10240
2025
Q2 		$373K Buy
152,238
+23,767
+18% +$120K ﹤0.01% 9853
2025
Q1 		$857K Buy
128,471
+78,751
+158% +$778K ﹤0.01% 7645
2024
Q4 		$625K Buy
49,720
+1,685
+4% +$25.4K ﹤0.01% 8125
2024
Q3 		$887K Sell
48,035
-2,462
-5% -$50.4K ﹤0.01% 7077
2024
Q2 		$1.09M Sell
50,497
-2,249
-4% -$51.7K ﹤0.01% 6378
2024
Q1 		$1.42M Buy
52,746
+14,080
+36% +$400K ﹤0.01% 6125
2023
Q4 		$1.16M Buy
38,666
+12,593
+48% +$278K ﹤0.01% 6620
2023
Q3 		$534K Sell
26,073
-7,836
-23% -$142K ﹤0.01% 8075
2023
Q2 		$674K Sell
33,909
-83,009
-71% -$1.68M ﹤0.01% 7611
2023
Q1 		$2M Buy
116,918
+69,841
+148% +$1.37M ﹤0.01% 5141
2022
Q4 		$921K Sell
47,077
-28,264
-38% -$521K ﹤0.01% 6372
2022
Q3 		$1.2M Buy
75,341
+49,887
+196% +$778K ﹤0.01% 6158
2022
Q2 		$350K Sell
25,454
-30,240
-54% -$360K ﹤0.01% 9153
2022
Q1 		$883K Sell
55,694
-9,273
-14% -$160K ﹤0.01% 7446
2021
Q4 		$1.42M Sell
64,967
-30,925
-32% -$844K ﹤0.01% 6344
2021
Q3 		$2.87M Buy
95,892
+15,149
+19% +$551K ﹤0.01% 5053
2021
Q2 		$3.58M Sell
80,743
-79,241
-50% -$3.44M ﹤0.01% 4679
2021
Q1 		$7.1M Buy
159,984
+59,387
+59% +$3.26M ﹤0.01% 3328
2020
Q4 		$5.52M Buy
100,597
+87,545
+671% +$3.19M ﹤0.01% 3270
2020
Q3 		$298K Buy
+13,052
New +$322K ﹤0.01% 8717
2020
Q2 		– Sell
-28,591
Closed -$515K – 10772
2020
Q1 		$399K Buy
+28,591
New +$566K ﹤0.01% 7405
2019
Q4 		– Sell
-21,026
Closed -$351K – 10454
2019
Q3 		$245K Sell
21,026
-47,505
-69% -$590K ﹤0.01% 8711
2019
Q2 		$1.03M Buy
+68,531
New +$1.2M ﹤0.01% 5593
2017
Q3 		– Sell
-30,744
Closed -$234K – 9481
2017
Q2 		$234K Buy
30,744
+7,051
+30% +$52.6K ﹤0.01% 8025
2017
Q1 		$190K Sell
23,693
-4,591
-16% -$30.9K ﹤0.01% 8042
2016
Q4 		$690K Buy
+28,284
New +$807K ﹤0.01% 6312
2016
Q2 		– Sell
-19,308
Closed -$572K – 9189
2016
Q1 		$572K Buy
19,308
+2,029
+12% +$60.9K ﹤0.01% 6167
2015
Q4 		$783K Buy
+17,279
New +$753K ﹤0.01% 5916

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group's RCKT Position: Q1 2026 in Review

Susquehanna International Group increased its Rocket Pharmaceuticals (RCKT) stake by 99% in Q1 2026, buying an estimated $764K and bringing the position to 385,639 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #7094.

Susquehanna International Group first reported a position in RCKT in Q4 2015 and has held it in 31 quarters since. The position peaked at $7.1M in Q1 2021. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Susquehanna International Group held 385,639 shares of Rocket Pharmaceuticals worth $1.38M as of Q1 2026.
  • Susquehanna International Group bought 192,209 Rocket Pharmaceuticals shares in Q1 2026, an estimated $764K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7094 holding.
  • Susquehanna International Group first reported a position in Rocket Pharmaceuticals in Q4 2015 and has held it in 31 quarters since.
  • Susquehanna International Group's Rocket Pharmaceuticals position peaked at $7.1M in Q1 2021.
  • 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.